Full Text
A Cost-effectiveness analysis of biomarker testing to target treatment to patients with mild cognitive impairment at increased risk of Alzheimer’s Disease

Abstract

Authors

T.L. Michaud K. Kuntz

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×